Infermedica, a Denver, CO-based digital health company, specializing in AI-powered solutions for symptom analysis and patient triage, raised $30m in Series B funding.
The round was led by One Peak, with participation from previous investors Karma Ventures, European Bank for Reconstruction and Development, Heal Capital, and Inovo Venture Partners. The new investment – which followed a Series A funding round just over a year ago – brings total funding to $44m.
The company intends to use the capital for further development of its Medical Guidance Platform (MGP), add new modules to cover the full primary care journey, increase their global commercial presence and expand their international, remote-first team of industry and medical experts.
Founded in 2012 in Poland by Piotr Orzechowski (CEO), Infermedica is a digital health company, specializing in AI-powered solutions for symptom analysis and patient triage. MGP leverages the same technology behind Infermedica’s successful Symptom Checker tool, which has been used by over 10 million users globally, to triage patients to the right level of care. The company plans to further develop the solution to enable handover to providers, including EHR integration, as part of the intake process, as well as automating follow-ups to close the feedback loop.
Since 2012, the company has supported industry leaders including Allianz, Global Excel, Gothaer, Microsoft, Optum, and Sana Kliniken. Infermedica is now being used in more than 30 countries, in 19 languages, and has completed more than 10 million successful health checks to date.
FinSMEs
26/01/2022